Netherlands· NL-3965ee14ac87
Gadoteerzuur Guerbet 0,5 mmol/ml, oplossing voor injectie in injectieflacons (voor meervoudig gebruik)
A gadotersäure product containing gadolinium (gd 3+) + gadoteerzuur, registered in Netherlands by GUERBET. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Gadotersäure is registered in 12 of 19 countries.
Countries holding a registration under ATC V08CA02 (gadotersäure), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Gadotersäure · ATC V08CA02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- GADOLINIUM (Gd 3+) + GADOTEERZUUR
- Manufacturer
- GUERBET
- Country
- Netherlands (NL)
- ATC code
- V08CA02
- ATC class
- Gadotersäure
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id107973
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for gadotersäure.
Graded by severity as the source publishes them — 31 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadotersäure · interactions on record
31 records
- 31 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V08CA02
Gadotersäure, as other registers publish it.
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
- BelgiumAcide Gadotérique Guerbet 0.5 mmol/mlGuerbet
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecd36ec6-7fc2-42c2-982b-cc7d0a830ed1 GET /v1/drugs/ecd36ec6-7fc2-42c2-982b-cc7d0a830ed1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h107973_smpc.pdf",
"strength": null,
"atc_label": "Gadoteric Acid",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg107973",
"excipients": [
"MEGLUMINE",
"WATER VOOR INJECTIE"
],
"substances": [
"GADOLINIUM (Gd 3+)",
"GADOTEERZUUR"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h107973.pdf",
"authorised_at": "2011/08/31",
"procedure_number": "NL/H/2028/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "107973",
"additional_monitoring": "N"
}See everything about gadotersäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.